Amprenavir

Therapeutic indications

Amprenavir is indicated for:

Population group: both men and women, only children (1 year - 12 years old)

Human immunodeficiency virus I infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Human immunodeficiency virus I infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Amprenavir is contraindicated in the following cases:

Hepatic insufficiency and additionally

Ritonavir

Rifampicin and additionally

Ritonavir

Lactation